ANTICIPATORY ANXIETY IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER
ANTICIPATORY ANXIETY IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST-CANCER
复制标题
DOI：
10.1037/0278-6133.12.6.469
复制
发表时间：
1993-11-01
影响因子：
4.2
通讯作者：
REDD, WH
中科院分区：
文献类型：
--
作者：
JACOBSEN, PB;BOVBJERG, DH;REDD, WH
这项研究调查了(A)癌症化疗前6次注射前焦虑的发生率和病程，以及(B)特质焦虑、副作用预期和治疗后副作用既往发生对注射前焦虑的贡献。53名接受乳腺癌辅助化疗的妇女参加了试验。焦虑在第1次输液前最为普遍和强烈。特质焦虑在第一次和随后的输液前都预示着焦虑。即使在考虑了特质焦虑和其他治疗后副作用后，先前出现的治疗后紧张也预示着随后的输液前的焦虑。结果从焦虑倾向、反应预期和经典条件作用的角度进行了讨论，这些因素可能在重复化疗前的焦虑发展中起作用。
This study examined (a) the prevalence and course of anxiety before the lst 6 infusions of cancer chemotherapy and (b) the contribution of trait anxiety, side effect expectations, and prior occurrence of posttreatment side effects to anxiety before infusions. Fifty-three women receiving adjuvant chemotherapy for breast cancer participated. Anxiety was most prevalent and intense before the 1st infusion. Trait anxiety predicted anxiety before both the lst and subsequent infusions. Prior occurrence of posttreatment nervousness also predicted anxiety before subsequent infusions, even after accounting for trait anxiety and other posttreatment side effects. Results are discussed in terms of the role that anxiety proneness, response expectancy, and classical conditioning may play in the development of anxiety before repeated chemotherapy infusions.